## **Core Concept**
The Human Papillomavirus (HPV) triage strategy involves testing for high-risk HPV types to manage cervical lesions and prevent progression to cervical cancer. This strategy is crucial for identifying individuals who require closer surveillance or immediate intervention.

## **Why the Correct Answer is Right**
HPV triage involves testing for high-risk HPV types, particularly HPV 16 and 18, which are responsible for a significant proportion of cervical cancer cases. The strategy helps in risk stratification and guides clinical management, including the decision for colposcopy, biopsy, or conservative management.

## **Why Each Wrong Option is Incorrect**
- **Option A:** HPV DNA testing for high-risk types is a valid approach in triage.
- **Option B:** p16/Ki-67 dual-stain cytology is an emerging method for triaging HPV-positive women, offering improved specificity over HPV testing alone.
- **Option C:** Reflex cytology (repeating a Pap smear) can be used in some triage strategies but is generally considered less efficient and less sensitive than HPV testing or biomarker-based approaches.
- **Option D:** HPV 16/18 genotyping is specifically recommended for triage in some guidelines, especially for managing women with an HPV-positive, cytology-negative result.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the **AS Cervical Cancer Screening Guidelines** and other international guidelines recommend HPV testing as the primary screening method, with cytology and HPV testing used in triage for managing screen-positive women. Understanding the specific indications and limitations of each triage strategy is crucial for optimal patient management.

## **Correct Answer:** . Reflex cytology.